<p><em>基於證據的風險評估工具實現 40% 的增長，醫療機構優先考慮通過個性化篩查進行早期檢測</em></p>
<p>, /PRNewswire/ -- Ikonopedia，乳腺影像報告和跟蹤解決方案的領導者，今天宣佈其風險意識™產品的採用顯著增長。這是一種基於網絡的 Tyrer-Cuzick 乳腺癌風險評估工具，專為放射科實踐和乳腺健康提供者設計。自 2023 年推出以來，Ikonopedia 的風險意識™已被超過 50 家醫療機構採用，截至 2025 年第三季度，代表着新客户年初至今超過 40% 的增長。</p>
<p>新採用者包括 BeSound、Mammoth Hospital、Snoqualmie Valley Health、Alameda Health System、Optum Health、Evans Memorial Hospital、Color Health、Premier Health Oncology，以及國際合作夥伴瑞士納沙泰爾的 Cabinet Cavenaghi - Faivre-Mayor 和越南的 FV Hospital。</p>
<p>&#34;我們很高興看到如此多的放射科團隊、醫院和健康系統接受風險意識，將個性化乳腺癌風險評估直接融入他們的護理模式，&#34;Ikonopedia 的總裁兼首席執行官 Emily Crane 表示。&#34;賦予女性個性化的風險信息可以導致更早的檢測和更好的結果。這是我們使命的核心——讓乳腺健康工具對每位患者和提供者都可及、高效且有意義。&#34;</p>
<p><strong>為什麼這很重要</strong></p>
<p>根據美國癌症協會的數據，乳腺癌仍然是美國女性中最常被診斷的癌症，也是美國女性癌症死亡的第二大原因。1 在全球範圍內，它是最常被診斷的癌症，也是女性癌症死亡的主要原因。2</p>
<p>Tyrer-Cuzick 模型是估算女性一生乳腺癌風險的最全面和廣泛使用的工具之一。3 它整合了一系列風險因素，包括家族史和 BRCA 等基因突變、乳腺密度、BMI、 reproductive 和激素變量、良性乳腺疾病，並在篩查人羣中進行了廣泛的驗證。</p>
<p>&#34;我們的使命是為乳腺護理帶來舒適、清晰和準確，而 Ikonopedia 的風險意識使我們能夠主動為患者提供更深入的乳腺癌風險因素見解，&#34;BeSound 的創始人兼首席執行官 Bailey Renger 表示。&#34;通過整合風險意識 API，我們已將 Tyrer-Cuzick 風險評估無縫地納入我們的系統和工作流程中，確保提供流暢而全面的患者護理體驗。&#34;</p>
<p>將這一基於證據的模型納入放射科工作流程，使臨牀醫生能夠識別可能受益於增強監測的患者，包括 MRI 篩查、基因諮詢或早期乳腺 X 光檢查。</p>
<p>正如 Ikonopedia 的醫療顧問、前 Intermountain Health 乳腺影像醫學主任 Brett T. Parkinson 博士在產品發佈時所指出的：</p>
<p>&#34;使乳腺影像中心能夠向患者提供 Tyrer-Cuzick 風險評估在早期檢測乳腺癌方面具有變革性意義。&#34;</p>
<p><strong>使風險評估成為常規</strong></p>
<p>Ikonopedia 的風險意識™為放射科和乳腺健康實踐提供了一個經過許可的基於網絡的 Tyrer-Cuzick 評估工具版本，可以集成到患者門户或在現場使用。這種可及性確保更多女性能夠主動評估自己的風險，並獲得個性化的後續護理建議。</p>
<p>&#34;乳腺健康風險評估不應是特權——它應該是患者護理的標準部分，&#34;Crane 補充道。&#34;風險意識幫助每個實踐，無論規模大小，提供這種主動和定製的基於證據的護理水平。&#34;</p>
<p><strong>關於 Ikonopedia Inc.</strong></p>
<p>Ikonopedia Inc.是乳腺影像報告和跟蹤解決方案的領導者，提供創新的基於雲的軟件，旨在提高乳腺影像的效率和準確性。Ikonopedia 由著名的乳腺放射科醫生創立，致力於通過先進的技術和以患者為中心的方法提升患者護理。瞭解更多信息，請訪問 www.ikonopedia.com。</p>
<p>參考文獻：</p>
<ol>
<li>https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/cancer-facts/cancer-facts-for-women.html</li>
<li>Bray F 等。2022 年全球癌症統計：GLOBOCAN 對 185 個國家 36 種癌症的發病率和死亡率估計。CA Cancer J Clin. 2024 年 5-6 月;74(3):229-263. doi: 10.3322/caac.21834. Epub2024 年 4 月 4 日。PMID: 38572751。</li>
<li>https://www.nationalbreastcancer.org/blog/tyrer-cuzick-model/</li>
</ol>
<p>來源 Ikonopedia</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REEyNjQ5NiZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcxNjIzUFJfTkVXU19VU1BSX19fX19EQTI2NDk2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REEyNjQ5NiZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcxNjIzUFJfTkVXU19VU1BSX19fX19EQTI2NDk2"/></p>

<p>Ikonopedia 宣佈其 Risk Aware™ 產品的採用顯著增長，這是一款基於網絡的乳腺癌風險評估工具。自 2023 年推出以來，已有超過 50 家醫療機構採用該工具，增長率達到 40%。該工具整合了 Tyrer-Cuzick 模型，幫助早期檢測和個性化護理。Ikonopedia 旨在使乳腺健康工具變得可及且高效，通過主動風險評估提升患者護理</p>

<p><em>Evidence-Based Risk Assessment Tool Achieves 40% Growth as Healthcare Organizations Prioritize Early Detection Through Personalized Screening</em></p>
<div class="lb-trans"><p><em>基於證據的風險評估工具實現 40% 的增長，醫療機構優先考慮通過個性化篩查進行早期檢測</em></p>
</div><p>, /PRNewswire/ -- Ikonopedia, a leader in breast imaging reporting and tracking solutions, today announced significant growth in adoption of its Risk Aware™ product, a web-based Tyrer-Cuzick Breast Cancer Risk Assessment tool designed for radiology practices and breast health providers. Since launching in 2023, Risk Aware™ by Ikonopedia has been adopted by more than 50 healthcare organizations through Q3 2025, representing over 40% year-to-date growth in new customers.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Ikonopedia，乳腺影像報告和跟蹤解決方案的領導者，今天宣佈其風險意識™產品的採用顯著增長。這是一種基於網絡的 Tyrer-Cuzick 乳腺癌風險評估工具，專為放射科實踐和乳腺健康提供者設計。自 2023 年推出以來，Ikonopedia 的風險意識™已被超過 50 家醫療機構採用，截至 2025 年第三季度，代表着新客户年初至今超過 40% 的增長。</p>
</div><p>New adopters include BeSound, Mammoth Hospital, Snoqualmie Valley Health, Alameda Health System, Optum Health, Evans Memorial Hospital, Color Health, Premier Health Oncology, and international partners Cabinet Cavenaghi - Faivre-Mayor in Neuchâtel, Switzerland and FV Hospital in Vietnam.</p>
<div class="lb-trans"><p>新採用者包括 BeSound、Mammoth Hospital、Snoqualmie Valley Health、Alameda Health System、Optum Health、Evans Memorial Hospital、Color Health、Premier Health Oncology，以及國際合作夥伴瑞士納沙泰爾的 Cabinet Cavenaghi - Faivre-Mayor 和越南的 FV Hospital。</p>
</div><p>&#34;We're thrilled to see so many radiology groups, hospitals, and health systems embracing Risk Aware to bring personalized breast cancer risk assessment directly into their care models,&#34; said Emily Crane, President and CEO of Ikonopedia. &#34;Empowering women with personalized risk information leads to earlier detection and better outcomes. That's the heart of our mission—to make breast health tools accessible, efficient, and meaningful for every patient and provider.&#34;</p>
<div class="lb-trans"><p>&#34;我們很高興看到如此多的放射科團隊、醫院和健康系統接受風險意識，將個性化乳腺癌風險評估直接融入他們的護理模式，&#34;Ikonopedia 的總裁兼首席執行官 Emily Crane 表示。&#34;賦予女性個性化的風險信息可以導致更早的檢測和更好的結果。這是我們使命的核心——讓乳腺健康工具對每位患者和提供者都可及、高效且有意義。&#34;</p>
</div><p><strong>Why It Matters</strong></p>
<div class="lb-trans"><p><strong>為什麼這很重要</strong></p>
</div><p>According to the American Cancer Society, breast cancer remains the most commonly diagnosed cancer among U.S. women and the second leading cause of cancer death in U.S. women.1 Worldwide, it is the most commonly diagnosed cancer and the leading cause of cancer death among women.2</p>
<div class="lb-trans"><p>根據美國癌症協會的數據，乳腺癌仍然是美國女性中最常被診斷的癌症，也是美國女性癌症死亡的第二大原因。1 在全球範圍內，它是最常被診斷的癌症，也是女性癌症死亡的主要原因。2</p>
</div><p>The Tyrer‑Cuzick model is one of the most comprehensive and widely used tools for estimating a woman's lifetime breast cancer risk.3 It integrates a broad set of risk-factors, including family history and genetic mutations such as BRCA, breast density, BMI, reproductive and hormonal variables, benign breast disease—and has undergone extensive validation in screening populations.</p>
<div class="lb-trans"><p>Tyrer-Cuzick 模型是估算女性一生乳腺癌風險的最全面和廣泛使用的工具之一。3 它整合了一系列風險因素，包括家族史和 BRCA 等基因突變、乳腺密度、BMI、 reproductive 和激素變量、良性乳腺疾病，並在篩查人羣中進行了廣泛的驗證。</p>
</div><p>&#34;Our mission is to bring comfort, clarity, and accuracy to breast care, and Ikonopedia's Risk Aware enables us to proactively provide our patients with deeper insights into their breast cancer risk factors,&#34; said Bailey Renger, Founder &amp; CEO of BeSound. &#34;By integrating the Risk Aware API, we've seamlessly incorporated the Tyrer-Cuzick risk assessment into our systems and workflow, ensuring a streamlined and comprehensive patient care experience.&#34;</p>
<div class="lb-trans"><p>&#34;我們的使命是為乳腺護理帶來舒適、清晰和準確，而 Ikonopedia 的風險意識使我們能夠主動為患者提供更深入的乳腺癌風險因素見解，&#34;BeSound 的創始人兼首席執行官 Bailey Renger 表示。&#34;通過整合風險意識 API，我們已將 Tyrer-Cuzick 風險評估無縫地納入我們的系統和工作流程中，確保提供流暢而全面的患者護理體驗。&#34;</p>
</div><p>Incorporating this evidence-based model into radiology workflows enables clinicians to identify patients who may benefit from enhanced surveillance, including MRI screening, genetic counseling, or early mammography.</p>
<div class="lb-trans"><p>將這一基於證據的模型納入放射科工作流程，使臨牀醫生能夠識別可能受益於增強監測的患者，包括 MRI 篩查、基因諮詢或早期乳腺 X 光檢查。</p>
</div><p>As Dr. Brett T. Parkinson, Ikonopedia medical advisor and former Medical Director of Breast Imaging at Intermountain Health, noted at the product's launch:</p>
<div class="lb-trans"><p>正如 Ikonopedia 的醫療顧問、前 Intermountain Health 乳腺影像醫學主任 Brett T. Parkinson 博士在產品發佈時所指出的：</p>
</div><p>&#34;Enabling breast imaging centers to offer the Tyrer-Cuzick risk assessment to their patients is game-changing in detecting breast cancer early.&#34;</p>
<div class="lb-trans"><p>&#34;使乳腺影像中心能夠向患者提供 Tyrer-Cuzick 風險評估在早期檢測乳腺癌方面具有變革性意義。&#34;</p>
</div><p><strong>Making Risk Assessment Routine</strong></p>
<div class="lb-trans"><p><strong>使風險評估成為常規</strong></p>
</div><p>Risk Aware™ by Ikonopedia provides radiology and breast health practices with a licensed, web-based version of the Tyrer-Cuzick assessment tool that can be integrated into patient portals or used onsite. This accessibility ensures more women can proactively assess their risk and receive personalized recommendations for follow-up care.</p>
<div class="lb-trans"><p>Ikonopedia 的風險意識™為放射科和乳腺健康實踐提供了一個經過許可的基於網絡的 Tyrer-Cuzick 評估工具版本，可以集成到患者門户或在現場使用。這種可及性確保更多女性能夠主動評估自己的風險，並獲得個性化的後續護理建議。</p>
</div><p>&#34;Breast health risk assessment should not be a privilege—it should be a standard part of patient care,&#34; added Crane. &#34;Risk Aware helps every practice, regardless of size, deliver that level of proactive and customized evidence-based care.&#34;</p>
<div class="lb-trans"><p>&#34;乳腺健康風險評估不應是特權——它應該是患者護理的標準部分，&#34;Crane 補充道。&#34;風險意識幫助每個實踐，無論規模大小，提供這種主動和定製的基於證據的護理水平。&#34;</p>
</div><p><strong>About Ikonopedia Inc.</strong></p>
<div class="lb-trans"><p><strong>關於 Ikonopedia Inc.</strong></p>
</div><p>Ikonopedia Inc. is a leader in breast imaging reporting and tracking solutions, providing innovative, cloud-based software designed to improve efficiency and accuracy in breast imaging. Founded by renowned breast radiologists, Ikonopedia is committed to enhancing patient care through state-of-the-art technology and a patient-centered approach. Learn more at www.ikonopedia.com.</p>
<div class="lb-trans"><p>Ikonopedia Inc.是乳腺影像報告和跟蹤解決方案的領導者，提供創新的基於雲的軟件，旨在提高乳腺影像的效率和準確性。Ikonopedia 由著名的乳腺放射科醫生創立，致力於通過先進的技術和以患者為中心的方法提升患者護理。瞭解更多信息，請訪問 www.ikonopedia.com。</p>
</div><p>References:</p>
<div class="lb-trans"><p>參考文獻：</p>
</div><ol>
<li>https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/cancer-facts/cancer-facts-for-women.html</li>
<li>Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751.</li>
<li>https://www.nationalbreastcancer.org/blog/tyrer-cuzick-model/</li>
</ol>
<div class="lb-trans"><ol>
<li>https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/cancer-facts/cancer-facts-for-women.html</li>
<li>Bray F 等。2022 年全球癌症統計：GLOBOCAN 對 185 個國家 36 種癌症的發病率和死亡率估計。CA Cancer J Clin. 2024 年 5-6 月;74(3):229-263. doi: 10.3322/caac.21834. Epub2024 年 4 月 4 日。PMID: 38572751。</li>
<li>https://www.nationalbreastcancer.org/blog/tyrer-cuzick-model/</li>
</ol>
</div><p>SOURCE Ikonopedia</p>
<div class="lb-trans"><p>來源 Ikonopedia</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REEyNjQ5NiZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcxNjIzUFJfTkVXU19VU1BSX19fX19EQTI2NDk2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DA26496&amp;Transmission_Id=202511171623PR_NEWS_USPR_____DA26496&amp;DateId=20251117"/></p>

Ikonopedia 擴大了 Risk Aware™ 的採用，因為放射科實踐將主動乳腺癌風險評估作為優先事項